Shire (LON:SHP)‘s stock had its “outperform” rating reiterated by stock analysts at Sanford C. Bernstein in a research report issued to clients and investors on Monday, Stock Ratings Network.com reports. They currently have a GBX 3,000 ($49.12) price target on the stock. Sanford C. Bernstein’s target price would suggest a potential upside of 8.23% from the stock’s previous close.
Shares of Shire (LON:SHP) opened at 2705.0249 on Monday. Shire has a 52-week low of GBX 1802.00 and a 52-week high of GBX 2939.00. The stock’s 50-day moving average is GBX 2724.66 and its 200-day moving average is GBX 2397.. The company’s market cap is £14.834 billion.
SHP has been the subject of a number of other recent research reports. Analysts at UBS AG downgraded shares of Shire to a “neutral” rating in a research note to investors on Monday. They now have a GBX 3,060 ($50.10) price target on the stock, down previously from GBX 3,100 ($50.75). Separately, analysts at Jefferies Group raised their price target on shares of Shire from GBX 3,100 ($50.75) to GBX 3,400 ($55.66) in a research note to investors on Monday, November 18th. They now have a “buy” rating on the stock. Finally, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Shire in a research note to investors on Friday, November 15th. They now have a GBX 3,400 ($55.66) price target on the stock. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating, sixteen have issued a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of GBX 2,295.07 ($37.57).
Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.